OLD Category: signatures

January 14, 2022 / Clin Cancer Res

  • Arend RC, Scalise CB, Gordon ER, Davis AM, Foxall ME, Johnston BE, Crossman DK, Cooper SJ
January 12, 2022 / Nat Commun

  • Wu H, He P, Ren Y, Xiao S, Wang W, Liu Z, Li H, Wang Z, Zhang D, Cai J, Zhou X, Jiang D, Fei X, Zhao L, Zhang H, Liu Z, Chen R, Li W, Wang C, Zhang S, Qin J, Nashan B, Sun C
January 10, 2022 / Nat Commun

  • Theocharidis G, Thomas BE, Sarkar D...Bhasin SS, Veves A, Bhasin M
January 10, 2022 / Front Oncol

  • Kulasinghe A, Monkman J, Shah ET, Matigian N, Adams MN, O’Byrne K
January 1, 2022 / Engineering Technologies and Clinical Translation (Chapter 11, Academic Press)

  • Fankhauser R, DePatie N, Berryman R, Lucero OM, Kulkarni RP
January 1, 2022 / Engineering Technologies and Clinical Translation (Chapter 9, Academic Press)

  • Wu YC, Pagacz J, Emery SC, Kron SJ, Lee SSY
December 28, 2021 / Immuno-Oncology and Technology (IOTECH)

  • Gupta S, Chen T, Destenaves B
December 20, 2021 / J Pathol

  • Joseph DB, Henry GH, Malewska A, Reese JC, Mauck RJ, Gahan JC, Hutchinson RC, Mohler JL, Roehrborn CG, Strand DW
December 10, 2021 / Emerg Top Life Sci

  • Karacosta LG
December 8, 2021 / Sci Rep

  • Finlin BS, Memetimin H, Confides AL, Zhu B, Westgate PM, Dupont-Versteegden EE, Kern PA
December 7, 2021 / Cancers (Basel)

  • Chakrabarti J, Koh V, Steele N...So JBY, Yong WP, Zavros Y
December 7, 2021 / Cancer Cell Int

  • Wang D, Xiong F, Wu G, Liu W, Wang B, Chen Y